We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FESTI:OMXICEFesti hf. Analysis

Data as of 2026-03-17 - not real-time

ISK 320.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Festi hf. is trading at ISK 320, notably below its 20‑day (≈ 334.7) and 50‑day (≈ 338.9) simple moving averages, while still sitting just above the 200‑day average (≈ 313.8). The RSI of 33.8 signals oversold conditions, yet the MACD histogram remains negative and the signal line is bearish, suggesting limited upside in the very short run. Volume has been increasing, providing some support for a potential bounce off the identified support level of 320, but the price is also hugging the lower bound of its recent range, facing resistance around 348.
Fundamentally, the stock appears undervalued: the discounted cash‑flow model suggests a fair value near ISK 366.8, a premium of over 15% to the current price. A PE of 16.2 is reasonable for a consumer‑cyclical retailer, and the dividend yield of 2.19% is backed by solid operating cash flow and a modest payout ratio. However, the balance sheet is leveraged, with a debt‑to‑equity ratio above 80%, and liquidity has slipped, as recent trading volume is well below the 10‑day average. Overall, the company offers a blend of value appeal and modest growth, tempered by sector cyclicality and Iceland’s geographic concentration.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is at key support and RSI indicates oversold conditions
  • Bearish MACD and neutral trend limit upside potential
  • Increasing volume suggests possible short‑term stabilization

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value exceeds current price by >15%
  • Attractive dividend yield with sustainable cash flow
  • Low beta (0.19) and moderate volatility support a stable return profile

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent earnings and cash generation despite high leverage
  • Sector positioning in specialty retail with steady demand
  • Long‑term upside from potential debt reduction and earnings growth

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin3.59%
P/E Ratio16.2
ROE13.64%
ROA5.38%
Debt/Equity81.53
P/B Ratio2.1
Op. Cash FlowISK15.8B
Free Cash FlowISK7.9B

Technical Analysis

TrendNeutral
RSI33.8
SupportISK 320.00
ResistanceISK 348.00
MA 20ISK 334.70
MA 50ISK 338.86
MA 200ISK 313.78
MACDBearish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair ValueISK 366.76
GradeUndervalued
TypeValue
Dividend Yield2.19%

Risk Assessment

Beta0.19
Volatility17.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.